产品名称: | Cedecea lapagei Grimont et al. |
---|---|
商品货号: | TS142401 |
Strain Designations: | CDC 0485-76 CIP 80.35, P.A.D. Grimont 004 |
Isolation: | Human throat, Canada |
Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Product Format: | freeze-dried |
Storage Conditions: | Freeze-Dried: 2°C to 8°C |
Preceptrol®: | no |
Type Strain: | yes (type strain) |
Medium: | ATCC® Medium 3: Nutrient agar or nutrient broth |
Growth Conditions: | Temperature: 26°C
Atmosphere: Aerobic |
Name of Depositor: | CDC |
Chain of Custody: | ATCC <-- CDC <-- Canadian CDC |
References: | Grimont PA, et al. Cedecea davisae gen. nov., sp. nov. and Cedecea lapagei sp. nov., new Enterobacteriaceae from clinical specimens. Int. J. Syst. Bacteriol. 31: 317-326, 1981. type strain type strain |
Cross References: | Nucleotide (GenBank) : AX109524 Sequence 257 from Patent WO0123604. |